NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/02/2024
Back to search
Official data from USPTO
KINLYTIC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
07/02/2024
Trademark type
Word
Nice classes
5
Filing date
09/13/2022
Registration date
07/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/02/2024
Last transaction
07/02/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Mississauga, CA
Examiner
CORWIN, KEVIN
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Microbix Biosystems Inc.
Representatives
Richard M. LaBarge MARSHALL, GERSTEIN & BORUN LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Antithrombotic drugs; thrombolytic drugs; Urokinase preparations for treating blood clots; Urokinase preparations for treating blood clotsadministered intravenously; Urokinase preparations for clearing catheters and cannulas; Urokinase preparations for the restoration of patency to intravenous cathetercentral venous catheterobstructed by clotted blood and fibrin; Urokinase preparations for treating pulmonary embolism; Urokinase preparations for treating the lysis of acute pulmonary emboli and pulmonary emboli accompanied by unstable hemodynamics; Urokinase preparations for treating thrombosis; Urokinase preparations for treating coronary artery thrombosis; Urokinase preparations for treating myocardial infarction; Urokinase preparations for the lysis of thrombi; Urokinase preparations for treating peripheral arterial and graft thromboembolic occlusion; Urokinase preparations for treating deep vein thrombosis; Urokinase preparations for treating pleural effusions; Urokinase preparations for treating peripheral arterial occlusion; Urokinase preparations for treating ischemic stroke; Urokinase preparations for treating lower limb ischemia
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/16/2024
PUBO
PUBLISHED FOR OPPOSITION
04/16/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/27/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/09/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/14/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/14/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/14/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/06/2023
GNRT
NON-FINAL ACTION E-MAILED
09/06/2023
CNRT
NON-FINAL ACTION WRITTEN
09/06/2023
DOCK
ASSIGNED TO EXAMINER
06/26/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/28/2022
NWAP
NEW APPLICATION ENTERED
09/16/2022
Continuous trademark protection
Get notified about every new filing that threatens KINLYTIC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.